Julia NEUGEBAUER

Person

Munchen, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Anti-BAFFR antibody formulations and methods of use thereof
- Patent number 12,054,555
- Issue date Aug 6, 2024
- Novartis AG
- Marta Cosenza
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies specific for human complement C5A receptor (C5AR)
- Patent number 12,018,072
- Issue date Jun 25, 2024
- Morphosys AG
- Julia Neugebauer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies targeting Glycoprotein VI
- Patent number 11,542,329
- Issue date Jan 3, 2023
- Morphosys AG
- Kerstin Uhland
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized antibodies for CD3
- Patent number 11,472,880
- Issue date Oct 18, 2022
- Morphosys AG
- Thomas Tiller
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fab molecules with a rodent hinge region and a non-rodent CH1 region
- Patent number 11,254,734
- Issue date Feb 22, 2022
- Morphosys AG
- Julia Neugebauer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-BAFFR antibody formulations and methods of use thereof
- Patent number 10,899,841
- Issue date Jan 26, 2021
- Novartis AG
- Marta Cosenza
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Angiopoetin-like 4 (ANGPTL4) antibodies and methods of use
- Patent number 9,988,443
- Issue date Jun 5, 2018
- Novartis AG
- John Trauger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating cardiovascular disorders with lectin-like oxidi...
- Patent number 9,988,455
- Issue date Jun 5, 2018
- Novartis AG
- Kurt Alex Heldwein
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Lectin-like oxidized LDL receptor 1 antibodies and methods of use
- Patent number 9,562,101
- Issue date Feb 7, 2017
- Novartis AG
- Kurt Alex Heldwein
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-BAFFR antibody formulations
- Patent number 9,458,240
- Issue date Oct 4, 2016
- Novartis Pharma AG
- Marta Cosenza
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods of use for therapeutic antibodies
- Patent number 9,382,326
- Issue date Jul 5, 2016
- Novartis AG
- Christoph Heusser
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods of use for therapeutic antibodies
- Patent number 9,340,620
- Issue date May 17, 2016
- Novartis AG
- Christoph Heusser
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods of use for therapeutic antibodies
- Patent number 8,106,163
- Issue date Jan 31, 2012
- Novartis AG
- Christoph Heusser
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
ANTIBODY FORMULATION
- Publication number 20250163170
- Publication date May 22, 2025
- Novartis AG
- Marta Cosenza
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS OF USE FOR THERAPEUTIC ANTIBODIES
- Publication number 20250034270
- Publication date Jan 30, 2025
- Novartis AG
- Christoph HUESSER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES TARGETING C5AR
- Publication number 20240400657
- Publication date Dec 5, 2024
- Morphosys AG
- Julia Neugebauer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES TARGETING C5AR
- Publication number 20240018225
- Publication date Jan 18, 2024
- Morphosys AG
- Julia Neugebauer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS AND METHODS OF USE FOR THERAPEUTIC ANTIBODIES
- Publication number 20220298251
- Publication date Sep 22, 2022
- Novartis AG
- Christoph HEUSSER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES TARGETING C5AR
- Publication number 20220135658
- Publication date May 5, 2022
- Morphosys AG
- Julia NEUGEBAUER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FAB Molecules with a Rodent Hinge Region and a Non-Rodent CH1 Region
- Publication number 20220135660
- Publication date May 5, 2022
- Morphosys AG
- Julia Neugebauer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY FORMULATION
- Publication number 20210269540
- Publication date Sep 2, 2021
- Novartis AG
- Marta Cosenza
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES TARGETING GLYCOPROTEIN VI
- Publication number 20210214435
- Publication date Jul 15, 2021
- Morphosys AG
- Kerstin UHLAND
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMANIZED ANTIBODIES FOR CD3
- Publication number 20200377594
- Publication date Dec 3, 2020
- Morphosys AG
- Thomas TILLER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FAB MOLECULES WITH A RODENT HINGE REGION AND A NON-RODENT CH1 REGION
- Publication number 20190345236
- Publication date Nov 14, 2019
- Morphosys AG
- Julia Neugebauer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY FORMULATION
- Publication number 20190194341
- Publication date Jun 27, 2019
- Novartis AG
- Marta COSENZA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS AND METHODS OF USE FOR THERAPEUTIC ANTIBODIES
- Publication number 20190135931
- Publication date May 9, 2019
- Novartis AG
- Christoph HEUSSER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY FORMULATION
- Publication number 20180179290
- Publication date Jun 28, 2018
- Novartis AG
- Marta Cosenza
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LECTIN-LIKE OXIDIZED LDL RECEPTOR 1 ANTIBODIES AND METHODS OF USE
- Publication number 20170260272
- Publication date Sep 14, 2017
- Novartis AG
- Kurt Alex HELDWEIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY FORMULATION
- Publication number 20160368999
- Publication date Dec 22, 2016
- Marta Cosenza
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS OF USE FOR THERAPEUTIC ANTIBODIES
- Publication number 20160347851
- Publication date Dec 1, 2016
- Novartis AG
- Christoph HEUSSER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANGIOPOETIN-LIKE 4 (ANGPTL4) ANTIBODIES AND METHODS OF USE
- Publication number 20160108110
- Publication date Apr 21, 2016
- Novartis AG
- John Trauger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LECTIN-LIKE OXIDIZED LDL RECEPTOR 1 ANTIBODIES AND METHODS OF USE
- Publication number 20140377281
- Publication date Dec 25, 2014
- Novartis AG
- Kurt Alex HELDWEIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY FORMULATION
- Publication number 20140186373
- Publication date Jul 3, 2014
- Marta Cosenza
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS OF USE FOR THERAPEUTIC ANTIBODIES
- Publication number 20120195913
- Publication date Aug 2, 2012
- Christoph Heusser
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS OF USE FOR THERAPEUTIC ANTIBODIES
- Publication number 20120183529
- Publication date Jul 19, 2012
- Christoph Heusser
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS OF USE FOR THERAPEUTIC ANTIBODIES
- Publication number 20100021452
- Publication date Jan 28, 2010
- Christoph Heusser
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Julia NEUGEBAUER

Person

Patents Grantslast 30 patents

Anti-BAFFR antibody formulations and methods of use thereof

Antibodies specific for human complement C5A receptor (C5AR)

Antibodies targeting Glycoprotein VI

Humanized antibodies for CD3

Fab molecules with a rodent hinge region and a non-rodent CH1 region

Anti-BAFFR antibody formulations and methods of use thereof

Angiopoetin-like 4 (ANGPTL4) antibodies and methods of use

Methods of treating cardiovascular disorders with lectin-like oxidi...

Lectin-like oxidized LDL receptor 1 antibodies and methods of use

Anti-BAFFR antibody formulations

Compositions and methods of use for therapeutic antibodies

Compositions and methods of use for therapeutic antibodies

Compositions and methods of use for therapeutic antibodies

Patents Applicationslast 30 patents

ANTIBODY FORMULATION

COMPOSITIONS AND METHODS OF USE FOR THERAPEUTIC ANTIBODIES

ANTIBODIES TARGETING C5AR

ANTIBODIES TARGETING C5AR

COMPOSITIONS AND METHODS OF USE FOR THERAPEUTIC ANTIBODIES

ANTIBODIES TARGETING C5AR

FAB Molecules with a Rodent Hinge Region and a Non-Rodent CH1 Region

ANTIBODY FORMULATION

ANTIBODIES TARGETING GLYCOPROTEIN VI

HUMANIZED ANTIBODIES FOR CD3

FAB MOLECULES WITH A RODENT HINGE REGION AND A NON-RODENT CH1 REGION

ANTIBODY FORMULATION

COMPOSITIONS AND METHODS OF USE FOR THERAPEUTIC ANTIBODIES

ANTIBODY FORMULATION

LECTIN-LIKE OXIDIZED LDL RECEPTOR 1 ANTIBODIES AND METHODS OF USE

ANTIBODY FORMULATION

COMPOSITIONS AND METHODS OF USE FOR THERAPEUTIC ANTIBODIES

ANGIOPOETIN-LIKE 4 (ANGPTL4) ANTIBODIES AND METHODS OF USE

LECTIN-LIKE OXIDIZED LDL RECEPTOR 1 ANTIBODIES AND METHODS OF USE

ANTIBODY FORMULATION

COMPOSITIONS AND METHODS OF USE FOR THERAPEUTIC ANTIBODIES

COMPOSITIONS AND METHODS OF USE FOR THERAPEUTIC ANTIBODIES

COMPOSITIONS AND METHODS OF USE FOR THERAPEUTIC ANTIBODIES